Your Health, We Care
The pralsetinib produced by Lucius has a specification of 100mg*120 pills.
If you want to purchase pralsetinib, you can contact us through the homepage.
Pralsetinib is indicated for the treatment of patients with metastatic (spread) non-small cell lung ···【more】
Recommended：262026-15-01
Pralsetinib is indicated for the treatment of patients with advanced or metastatic (spread) medullar···【more】
Recommended：272026-15-01
Pralsetinib is indicated for the treatment of patients with metastatic (spread) non-small cell lung cancer (NSCLC) whose tumors harbor a RET fusion-positive gene.Latest Price of Pr···【more】
Article source：Lucius LaosRelease date：2026-01-15Recommended：26
Pralsetinib is indicated for the treatment of patients with advanced or metastatic (spread) medullary thyroid carcinoma (MTC) whose tumors harbor abnormal RET genes (RET-mutant typ···【more】
Article source：Lucius LaosRelease date：2026-01-15Recommended：27
Pralsetinib is a selective RET kinase inhibitor indicated for the treatment of RET-fused cancers (NSCLC) and RET-altered thyroid cancers.Where to buy Pralsetinib is reliable?1. Hos···【more】
Article source：Lucius LaosRelease date：2024-11-14Recommended：231
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
